OSF1在毕赤酵母菌中的分泌表达及其生物活性

为了研究人成骨细胞刺激因子(Human osteoblast-stimulating factor,OSF-1)的生物学活性,构建OSF-1高效毕赤酵母表达菌株并表达纯化具有生物活性的OSF-1。首先通过全基因人工合成的方法合成人osf-1基因,并克隆至毕赤酵母分泌表达载体pPIC9K,构建重组表达质粒pPIC9K/osf-1,线性化后电转化酵母宿主菌GS115,构建P.pastoris GS115/pPIC9K/osf-1,经MD、G418-YPD平板和PCR法筛选,获得多拷贝转化子。阳性表达菌株在25℃,经1%的甲醇诱导表达96 h,重组蛋白的表达量达到最大。经SDS-PAGE电泳分析所表达的重组蛋白约为18 kDa,与人成骨细胞刺激因子相符。表达上清经SP-Sephadex C-50离子交换层析进行纯化,得到纯度达98%以上的OSF-1。Western blotting鉴定该蛋白对人成骨细胞刺激因子抗体具有良好的抗原性。生物活性测定表明提纯的OSF-1能促进鼠成骨细胞MC3T3-E1的增殖和分化。利用重组毕赤酵母高效分泌表达了有生物活性的OSF-1,为进一步开展其抗骨质疏松活性研究及产业化开发奠定了基础。     

人三叶因子3在毕氏酵母中的表达及生物活性分析

利用PCR方法在人胎儿胎盘cDNA中扩增了人三叶因子3基因（hTFF3）,插入到含有AOX1启动子和α－因子信号肽序列的表达载体pPIC9K中,采用毕氏酵母表达系统对其进行了高效的分泌表达,并用G418筛选高拷贝整合转化子。2％甲醇诱导酵母表达48h后,上清经SDS－PAGE和Western印迹证明重组蛋白质以双体的形式分泌表达,占总蛋白质的45％,能被抗hTFF3抗体所识别。表达产物经S－Sepharose、Q-Sepharose离子交换及Sephacryl S-100纯化后纯度达到95％以上。体内生物学活性研究证实hTFF3可有效的防止盐酸诱导的大鼠胃溃疡。     

三叶因子Bm-TFF2突变体在原核体系中的表达及促细胞迁移活性

大蹼铃蟾三叶因子Bm-TFF2具有较人TFF2更强的促细胞迁移和抗凋亡活性。该研究利用RT-PCR方法扩增得到野生型Bm-TFF2的基因,然后分别构建N端、C端和分子中两个精氨酸突变的突变体,最后连接表达载体产生pET32a(+)/Bm-TFF2突变型重组质粒,转入大肠杆菌中,经37℃培养,IPTG诱导,其融合蛋白主要存在于包涵体中,用组氨酸标签的亲合柱纯化溶解后的包涵体上清,进一步用RP-HPLC纯化得到硫氧还蛋白(TRX)/Bm-TFF2突变型融合蛋白。通过SDS-PAGE和Westernblotting检测分析其纯度和特异性。最终,从1L培养基中得到20mg纯度为95%的三种重组突变型融合蛋白。三种突变型重组蛋白都具有剂量依赖性的促细胞迁移活性,并且其活性无显著差异。该研究为进一步研究Bm-TFF2结构和功能的关系以及揭示其作用的分子机制奠定了基础。     

人可溶性gp190在酵母Pichia pastoris中的表达

人可溶性gPl90(sgp190)是白血病抑制因子(LIF)的可溶性受体,可能在LIF行使众多生物学功能中扮演着重要的角色。为获得这一蛋白以研究它在人体内的生物学活性,在酵母Pichia pastoris中实现了重组sgp190分泌表达。利用基因重组技术,将编码人可溶性gP190(LlF受体α亚基gP190胞外区)cDNA克隆到毕赤酵母Pichia pastoris分泌表达载体pPIC9K,构建了重组表达质粒pPIC9K-sgp190。原生质体法转染Pichia pastoris GS115菌株,经过G418筛选,得到了高效分泌表达sgp190蛋白的毕赤酵母菌株GS115／pPIC9K-sgp190,sgp190蛋白占摇瓶培养表达上清中总蛋白质的26％。经初步纯化,对表达产物的性质鉴定表明,其分子量约125kD,具有免疫活性。对sgp190体外活性分析表明它能够抑制LIF诱导滋养层细胞分泌hCG。     

重组萝卜磷脂氢谷胱甘肽过氧化物酶在毕赤酵母优化表达初步纯化与鉴定

将萝卜磷脂氢谷胱甘肽过氧化物酶（RsPHGPx）基因插入到分泌表达载体pPIC9K中,转化巴斯德毕赤酵母GS115细胞,筛选具有G418抗性的单拷贝转化子。经过优化表达条件,RsPHGPx在1%甲醇、pH6.0、28℃条件下诱导60h后得到最大表达量,产率约为102 mg/L。通过硫酸铵分级沉淀、脱盐柱脱盐、凝胶过滤等纯化步骤,得到了90%以上纯度的RsPHGPx．活性分析显示纯化获得的RsPHGPx具有依赖于GSH的还原活性, 比活性为4.2μmol/min·mg,为获得大量RsPHGPx而用于应用开发研究奠定了基础。     

链霉菌Streptomyces olivaceoviridis A1 木聚糖酶基因xynA在大肠杆菌及毕赤酵母中的高效表达

从橄榄绿链霉菌StreptomycesolivaceoviridisA1中克隆出木聚糖酶基因xynA ,将带与不带原基因信号肽编码序列的xynA分别以正确的阅读框架克隆到大肠杆菌表达载体pET 2 2b( )上的pellB信号肽编码序列之后 ,得到 2种构建的重组载体 ,在重组大肠杆菌中木聚糖酶得到了表达 ,表达产物具有生物活性。进一步将不带原基因信号肽编码序列的xynA插入到毕赤酵母转移载体pPIC9中 ,转化毕赤酵母得到重组子 ,在重组子中木聚糖酶基因得到了高效分泌表达 ,在摇床培养水平上的表达量达到 2 0 0mg L ,且表达产物具有生物学活性。     

狐狸生长激素基因的克隆及其在毕赤酵母中的表达

为制备重组狐狸生长激素(fGH),采用RT-PCR方法,从银狐垂体中扩增fGHcDNA基因,利用SnaBI和NotI位点将fGH基因插入到酵母分泌型表达载体pPIC9K中α-因子信号肽的下游,构建成fGH基因的酵母分泌型表达载体pPIC9K/fGH,载体经SalI酶切线性化后,通过电转移将线性化的pPIC9K/fGH转化到组氨酸缺陷型酵母宿主菌GS115中。然后利用不含氨基酸的以葡萄糖为碳源的培养基(MD)和以甲醇为碳源的培养基(MM)筛选出组氨酸His+型和甲醇利用正型(Mut+)酵母重组体,再经G418加压筛选出高拷贝fGH基因的重组酵母,经摇瓶发酵培养和甲醇诱导使fGH进行分泌表达。结果表明本实验扩增的fGH基因序列与GenBank发表的序列基本一致,发酵液经SDS-PAGE和Western blotting检测证明构建的重组酵母能够分泌表达fGH,表达的fGH占发酵液总蛋白的34%,表达量达119mg/L发酵液。     

信号肽序列对毕赤酵母表达外源蛋白质的影响

乙醇氧化酶启动子被分离、克隆 ,并建立了转化方法后 ,毕赤酵母已被发展成为一种高效的外源蛋白表达宿主。为了进一步提高外源蛋白质的分泌表达 ,对信号肽序列进行了研究。首先按毕赤酵母的偏爱密码合成了酿酒酵母的α因子信号肽序列MF4I,随后在MF4I信号肽序列的N端分别引入 1～ 10个毕赤酵母Aox1蛋白质的N端氨基酸 ,构成 10种不同的分泌信号肽序列 ,10种不同的分泌信号肽序列被用于植酸酶基因的毕赤酵母分泌表达。以上新的信号肽序列都可使植酸酶的分泌表达量增加 ,而以N端增加A、I、P三个氨基酸的信号肽序列引起的提高最大 ;和野生型的酿酒酵母α因子信号肽序列相比 ,使植酸酶分泌表达量增加 5倍 ,摇瓶中植酸酶的分泌表达量为 90mg/L。此外在MF4I信号肽的引导序列和内切蛋白酶间增加了EEAEAEAEP和K共 10个氨基酸 ,进一步提高信号肽的分泌效率 ,使表达又提高约 35 % ,使得摇瓶中酸性植酸酶的表达量达到 12 0mg/L ,是pPCI9K表达量的 8倍。     

人小肠三叶因子在毕赤酵母中克隆表达及对肠粘膜修复作用的研究

为了研究人肠三叶因子(hITF)对肠粘膜的保护作用,利用RT-PCR从肠粘膜中扩增出hITF基因片段,与诱导分泌型毕赤酵母载体pPIC9连接构建了重组质粒pPIC9hITF,重组质粒转化至宿主菌GS115,经过PCR鉴定和转化子发酵筛选,得到一个重组毕赤酵母高产菌株GS115/pPIC9hITF。在5L发酵罐中用基本盐培养基培养重组菌株,添加甲醇诱导表达hITF,离心收集的上清液通过离心交换层析纯化得到hITF。质谱鉴定结果表明纯化的hITF与天然提取产品在N端序列上完全相同。细胞实验和动物实验结果表明重组hITF能够促进细胞迁移,并可以保护肠粘膜免受有害因子的侵袭,保持了较好的生物学活性。     

人肝再生增强因子在毕赤酵母中的表达、纯化和生物学活性的研究

肝再生增强因子（ALR）是一类胞源性肝细胞生长因子。为在毕赤酵母中分泌表达人肝再生增强因子（rhALR）,以色谱法分离纯化后进行体外活性研究,构建表达载体pPICZαA- ALR,经电穿孔转入毕赤酵母中,用0.5％甲醇诱导表达;重组酵母培养上清经SDS-PAGE电泳和western blot鉴定后表明, rhALR以分子量为30kD的二聚体为主;定量分析结果表明,重组酵母培养上清中rhALR约占总蛋白的66％,表达量约为40mg/L;经DEAE柱和G75柱纯化后,获得的rhALR纯度大于95％,得率为52％;体外生物学活性实验表明,rhALR能明显促进HepG2、SMMC-7721和NIH-3T3细胞的增殖。     

Bm-TFF2, a toad trefoil factor, promotes cell migration, survival and wound healing

Toad skin is naked and continually confronted by various injurious factors. Constant skin renewal and repairs occur frequently. However, the mechanisms of the renewal and repair have not clearly elucidated. In our previous work, a trefoil factor (TFF), Bm-TFF2, has been purified from the Bombina maxima skin and characterized as a platelet agonist. The mRNA of TFFs in toad skin was up-regulated greatly during the metamorphosis, indicating a pivotal role of TFFs in amphibian skin. Here, we presented the effects of Bm-TFF2 on the cell migration, apoptosis and proliferation. Bm-TFF2 bound to epithelial cells and showed strong cell motility activity. At the concentrations of 1-100 nM, Bm-TFF2-induced migration of human epithelial AGS and HT-29 cells, and rat intestinal epithelial IEC-6 cell lines. The in vitro wound healing assay also verified the activity of Bm-TFF2. Bm-TFF2 could also inhibit cell apoptosis induced by ceramide and sodium butyrate. The cell migration-promoting activity was abolished by MEK1 inhibitors, U0126 and PD98059, suggesting that ERK1/2 activation is crucial for Bm-TFF2 to stimulate cell migration. Taken together, Bm-TFF2 promoted wound healing by stimulating cell migration via MAPK pathway and preventing cell apoptosis. The potent biological activity of Bm-TFF2 makes it a useful molecular tool for further studies of structure-function relationship of the related human TFFs.     

Bm-TFF2, a trefoil factor protein with platelet activation activity from frog Bombina maxima skin secretions

In mammals, trefoil factor family (TFF) proteins are involved in mucosal maintenance and repair, and they are also implicated in tumor suppression and cancer progression. A novel two domain TFF protein from frog Bombina maxima skin secretions (Bm-TFF2) has been purified and cloned. It activated human platelets in a dose-dependent manner and activation of integrin alpha(IIb)beta(3) was involved. Aspirin and apyrase did not largely reduce platelet response to Bm-TFF2 (a 30% inhibition), indicating that the aggregation is not substantially dependent on ADP and thromboxane A2 autocrine feedback. Elimination of external Ca(2+) with EGTA did not influence the platelet aggregation induced by Bm-TFF2, meanwhile a strong calcium signal (cytoplasmic Ca(2+) release) was detected, suggesting that activation of phospholipase C (PLC) is involved. Subsequent immunoblotting revealed that, unlike in platelets activated by stejnulxin (a glycoprotein VI agonist), PLCgamma2 was not phosphorylated in platelets activated by Bm-TFF2. FITC-labeled Bm-TFF2 bound to platelet membranes. Bm-TFF2 is the first TFF protein reported to possess human platelet activation activity.     

植物甜蛋白des-pGlu1-Brazzein的密码子优化及其在毕氏酵母中的表达

根据甜蛋白des-pGlu1-Brazzein的成熟区氨基酸序列,按照酵母密码子的偏好优化其编码序列,合成了4对末端具粘合位点的寡聚核苷酸序列,经连接、PCR扩增后得到了179 bp的des-pGlu1-Brazzein编码序列,插入到pPIC9K载体中,构建了重组表达载体pPIC9K-Bra。经酶切、电击转化到毕赤酵母菌GS115中。酵母工程菌株经筛选鉴定后诱导表达,目的蛋白的表达量约占上清总蛋白的51.6％,分离纯化后的des-pGlu1-Brazzein具有一定的甜度。     

组蛋白去甲基化酶JMJD1A

组蛋白翻译后修饰可影响特定基因的表达,从而在多个生理过程中发挥重要作用,是当前生命科学领域的研究热点之一。组蛋白去甲基化酶JMJD1A可催化一甲基化和二甲基化的H3K9(H3K9me1/2)去甲基化,通过解除组蛋白抑制效应而调节基因表达。JMJD1A拥有广泛的生物学功能,参与多种生物学过程包括核受体激活、精子生成、能量代谢、低氧调节和癌症发生等。本文就JMJD1A的特征及功能作一综述。     

Down-Regulation of Gab1 Inhibits Cell Proliferation and Migration in Hilar Cholangiocarcinoma

Hilar cholangiocarcinoma is a highly aggressive malignancy originating from the hilar biliary duct epithelium. Due to few effective comprehensive treatments, the prognosis of hilar cholangiocarcinoma is poor. In this study, immunohistochemistry was first used to detect and analyze the expression of Gab1, VEGFR-2, and MMP-9 in hilar cholangiocarcinoma solid tumors and the relationships to the clinical pathological features. Furthermore, Gab1 and VEGFR-2 siRNA were used to interfere the hilar cholangiocarcinoma cell line ICBD-1 and then detect the PI3K/Akt signaling pathway, MMP-9 levels and malignant biological behaviors of tumor cells. The data showed that 1. Gab1, VEGFR-2, and MMP-9 were highly expressed and positively correlated with each other in hilar cholangiocarcinoma tissues, which were related to lymph node metastasis and differentiation. 2. After Gab1 or VEGFR-2 siRNA interference, PI3K/Akt pathway activity and MMP-9 levels were decreased in ICBD-1 cells. At the same time, cell proliferation decreased, cell cycle arrested in G1 phase, apoptosis increased and invasion decreased. These results suggest that the expression of Gab1, VEGFR-2, and MMP-9 are significantly related to the malignant biological behavior of hilar cholangiocarcinoma. Gab1 regulates growth, apoptosis and invasion through the VEGFR-2/Gab1/PI3K/Akt signaling pathway in hilar cholangiocarcinoma cells and influences the invasion of tumor cells via MMP-9.     

Osteoprotegerin differentially regulates protease expression in osteoclast cultures

Cysteine proteases and matrix metalloproteinases (MMPs) are important factors in the degradation of organic matrix components of bone. Osteoprotegerin (OPG) is an osteoblast-secreted decoy receptor that inhibits osteoclast differentiation and activation. This study investigated the direct effects of human OPG on cathepsin K, MMP-9, MMP-2, and tissue inhibitors of metalloproteinases (TIMP1 and TIMP2) expressed by purified rabbit osteoclasts. The expression of two osteoclast markers, namely tartrate-resistant acid phosphatase (TRAP) and cathepsin K, was inhibited by 100 ng/mL hOPG, whereas MMP-9 expression was enhanced. Gelatinase activities were measured using a zymographic assay, and hOPG was shown to enhance both pro-MMP-9 and MMP-2 activities. Concomitantly, TIMP1 expression was greatly stimulated by hOPG, whereas TIMP2 mRNA levels were not modulated. Overall, these results show that hOPG regulates the proteases produced by purified osteoclasts differentially, producing a marked inhibitory effect on the expression of cathepsin K, the main enzyme involved in bone resorption.     

Comparison of some minor activities accompanying a preparation of sodium-plus-potassium ion-stimulated adenosine triphosphatase from pig brain

1. An ATPase (adenosine triphosphatase) preparation obtained from pig brain microsomes by treatment with sodium iodide showed four apparently different ouabain-sensitive activities under various conditions. They were (a) ouabain-sensitive Mg(2+)-stimulated ATPase, (b) K(+)-stimulated ATPase, (c) (Na(+),K(+))-stimulated ATPase and (d) Na(+)-stimulated ATPase activities. 2. These activities showed the same substrate specificity, ATP being preferentially hydrolysed and CTP slightly. AMP was not hydrolysed. 3. These activities were inhibited by low concentration of ouabain. The concentration producing 50% inhibition was 0.1mum for ouabain-sensitive Mg(2+)-stimulated ATPase, 0.2mum for K(+)-stimulated ATPase, 0.1mum for (Na(+),K(+))-stimulated ATPase and 0.003mum for Na(+)-stimulated ATPase activity. 4. The ouabain-sensitive ATPase activities were inactivated by N-ethylmaleimide but the insensitive ATPase activity was not. 5. The three ouabain-sensitive ATPase activities were inhibited about 50% by 1mm-Ca(2+), whereas the ouabain-sensitive Mg(2+)-stimulated ATPase activity was activated by the same concentration of Ca(2+). The preparation was treated with ultrasonics at 20kcyc./sec. The 2min. ultrasonic treatment inactivated the ATPase activities by 50%. 7. The temperature coefficient Q(10) was 6.6 for K(+)-stimulated ATPase activity, 3.7 for (Na(+),K(+))-stimulated ATPase and 2.6 for Na(+)-stimulated ATPase. 8. Organic solvents inactivated the ATPase activities, to which treatment the K(+)-stimulated ATPase was the most resistant. 9. The phosphorylation of the enzyme preparation became less dependent on Na(+) with decreasing pH. This Na(+)-independent phosphorylation at low pH was sensitive to K(+) and hydroxylamine as well as the Na(+)-dependent phosphorylation at neutral pH.     

Synthesis and purification of a deleted human growth hormone, hGH delta 135-146: sensitivity to plasmin cleavage and in vitro and in vivo bioactivities

Proteolytically cleaved human 22 kDa growth hormone (22K hGH) between the amino acid residues 134 and 150 by plasmin or other proteases in vitro has been reported to be most active in growth promoting activity. In this study a deleted mutant hGH lacking amino acid residues from 135 to 146 and having more sensitivity to plasmin digestion was produced using the inverse polymerase chain reaction method and the Escherichia coli expression system. The mutant, hGH delta 135-146, was folded and purified effectively and found to be more sensitive to plasmin cleavage to form the two-chain form in vitro. The biological activities of this plasmin sensitive hGH delta 135-146 were tested by in vitro cell proliferation assays and in vivo growth promoting assay. In Ba/F3-hGHR cells, which express receptors for hGH, hGH delta 135-146 showed 10-20% less growth promoting activity than 22K hGH, but expressed comparable quantities of IGF-I mRNA to that of 22K hGH. In Nb2 rat lymphoma cells, which proliferate in response to hGH via the lactogenic receptors, hGH delta 135-146 showed equivalent activities to those of 22K hGH at lower concentrations. By the body weight gain test using hypophysectomized rats, a lower dose (2.5 nmol kg-1) of hGH delta 135-146 exhibited an equivalent activity to that of wild type 22K hGH, but a higher dose (25 nmol kg-1) of the mutant showed less growth promoting activity than 22K hGH. These results indicated that the plasmin sensitive recombinant hGH delta 135-146 failed to show higher biological activity than the 22K hGH in vivo, suggesting the unsuccessful formation of the active two-chain form in vivo.